Table 3 The primary combined and secondary renal and cardiovascular outcomes probability in a different risk groups (presence or absence of metabolic syndrome and maintained or attenuated heart rate recovery)
From: The prognostic role of heart rate recovery after exercise and metabolic syndrome in IgA nephropathy
Primary combined endpoints | Secondary renal endpoints | Secondary cardiovascular endpoints | ||||
|---|---|---|---|---|---|---|
Risk groups | Odds Ratio (conf. Int.) | p | Odds Ratio (conf. Int.) | p | Odds Ratio (conf. Int.) | p |
Met sy−/HRR ≥ 23 | 1.0 | – | 1.0 | – | 1.0 | – |
Met sy−/HRR < 23 | 1.6 (0.565–4.321) | 0.390 | 1.9 (0.527–4.821) | 0.332 | 1.4 (0.229–3.112) | 0.687 |
Met sy+/HRR ≥ 23 | 2.8 (0.722–10.982) | 0.136 | 3.1 (0.577–11.456) | 0.185 | 2.2 (0.279–8.987) | 0.494 |
Met sy+/HRR < 23 | 6.4 (2.550–16.149) | < 0.0001 | 6.5 (1.969–16.321) | 0.002 | 5.1 (1.129–14.867) | 0.034 |